BIOSECURE Act

News

US vulnerable to China's API dominance, says report

China has such a dominant position in pharmaceutical ingredient production that there is a risk it will weaponise access, says a Congressional report.

News

Amid BIOSECURE Act speculation, WuXi AppTec sells unit

WuXi AppTec has agreed to sell a business unit serving the cell and gene therapy (CGT) sector to private equity firm Altaris for an undisclosed sum

News

Relief for Chinese biotechs as BIOSECURE Act delayed

US legislation that could have a big impact on the businesses of five biotechs with links to China now looks unlikely to be passed this year.

News

BIOSECURE Act clears House vote

The US House of Representatives comprehensively voted in favour of the BIOSECURE Act, which will prohibit businesses in the US from contracting with various Chinese firms on national securi

News

WuXi buoyed as BIOSECURE Act is left out of US spending bill

Shares in WuXi Biologics and WuXi AppTec have tracked up after the BIOSECURE Act – which could have profound effects on their businesses in the US – was omitted from legislation due to be f

Market Access

US-Chinese relations put the brakes on biotech cooperation

The China-US trade war has spread to the biotech industry, as the US BIOSECURE Act looks to dampen Chinese influence on a range of services, including contract manufacturing.

US vulnerable to China's API dominance, says report

Amid BIOSECURE Act speculation, WuXi AppTec sells unit

Relief for Chinese biotechs as BIOSECURE Act delayed

BIOSECURE Act clears House vote

WuXi buoyed as BIOSECURE Act is left out of US spending bill

US-Chinese relations put the brakes on biotech cooperation

NHS staff 'feel unprepared for digital transformation'

How to meet your physicians where they are online

BIOSECURE Act

Editor's Picks